Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

HNSBF

Hansa Biopharma AB (publ)

USD

Set alert

Price alert · HNSBF

All alert types
3.29 USD 0.00 0.00%
As of Oct 29, 2026
2.93 Day range 2.93
2.90 52-week range 4.58
YTD
+13.02%
1 year
-28.19%
Open
2.93
Prev close
3.29
Mkt cap
328.02M
Vol
150
Avg vol
93
EPS
-0.84
P/E
0.00
More statistics
Low
2.93
High
2.93

5D chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The five-day price history for HNSBF has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

-0.24 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -4.1×
FY 2016: -37.2×FY 2017: -48.2×FY 2018: -36.7×FY 2019: -9.5×FY 2020: -24.3×FY 2021: -6.8×FY 2022: -3.8×FY 2023: -1.7×FY 2024: -2.6×FY 2025: -4.1×
FY 2016 5y median -3.8× FY 2025
P/S 9.8×
FY 2016: 1604×FY 2017: 2473×FY 2018: 2713×FY 2019: 1013×FY 2020: 1677×FY 2021: 110×FY 2022: 15.2×FY 2023: 10.5×FY 2024: 12.2×FY 2025: 9.8×
FY 2016 5y median 12.2× FY 2025
P/B -24.5×
FY 2016: 14.6×FY 2017: 13.5×FY 2018: 10.6×FY 2019: 6.1×FY 2020: 8.2×FY 2021: 4.9×FY 2022: 3.9×FY 2023: -8.4×FY 2024: -3.5×FY 2025: -24.5×
FY 2016 5y median -3.5× FY 2025
P/FCF -4.0×
FY 2016: -43.3×FY 2017: -55.8×FY 2018: -44.0×FY 2019: -10.1×FY 2020: -35.2×FY 2021: -7.7×FY 2022: -4.6×FY 2023: -1.9×FY 2024: -3.1×FY 2025: -4.0×
FY 2016 5y median -4.0× FY 2025
EV/EBITDA -6.5×
FY 2016: -36.5×FY 2017: -46.1×FY 2018: -35.3×FY 2019: -9.2×FY 2020: -22.0×FY 2021: -5.8×FY 2022: -3.0×FY 2023: -2.2×FY 2024: -4.3×FY 2025: -6.5×
FY 2016 5y median -4.3× FY 2025
EV/Sales 10.8×
FY 2016: 1521×FY 2017: 2304×FY 2018: 2582×FY 2019: 962×FY 2020: 1491×FY 2021: 91.6×FY 2022: 10.6×FY 2023: 11.5×FY 2024: 16.1×FY 2025: 10.8×
FY 2016 5y median 11.5× FY 2025
FCF Yield -25.2%
FY 2016: -2.3%FY 2017: -1.8%FY 2018: -2.3%FY 2019: -9.9%FY 2020: -2.8%FY 2021: -13.0%FY 2022: -21.6%FY 2023: -53.9%FY 2024: -32.4%FY 2025: -25.2%
FY 2016 5y median -25.2% FY 2025

Profitability

Gross Margin 62.4%
FY 2016: 91.6%FY 2017: 93.6%FY 2018: 72.7%FY 2019: 74.3%FY 2020: 83.7%FY 2021: 54.5%FY 2022: 75.1%FY 2023: 52.9%FY 2024: 51.2%FY 2025: 62.4%
FY 2016 5y median 54.5% FY 2025
Operating Margin -233.0%
FY 2016: -4309.2%FY 2017: -5115.7%FY 2018: -7340.6%FY 2019: -10691.7%FY 2020: -6933.5%FY 2021: -1614.6%FY 2022: -380.9%FY 2023: -588.0%FY 2024: -372.3%FY 2025: -233.0%
FY 2016 5y median -380.9% FY 2025
Net Margin -240.3%
FY 2016: -4309.0%FY 2017: -5132.5%FY 2018: -7384.6%FY 2019: -10701.8%FY 2020: -6901.5%FY 2021: -1618.4%FY 2022: -395.5%FY 2023: -620.3%FY 2024: -470.9%FY 2025: -240.3%
FY 2016 5y median -470.9% FY 2025
ROE 600.2%
FY 2016: -39.2%FY 2017: -28.0%FY 2018: -28.8%FY 2019: -64.0%FY 2020: -33.9%FY 2021: -72.4%FY 2022: -101.4%FY 2023: 495.4%FY 2024: 136.8%FY 2025: 600.2%
FY 2016 5y median 136.8% FY 2025
ROIC -57.5%
FY 2016: -39.0%FY 2017: -27.6%FY 2018: -28.2%FY 2019: -62.6%FY 2020: -31.9%FY 2021: -64.5%FY 2022: -41.2%FY 2023: -111.9%FY 2024: -115.4%FY 2025: -57.5%
FY 2016 5y median -64.5% FY 2025
ROA -45.8%
FY 2016: -35.8%FY 2017: -26.0%FY 2018: -26.2%FY 2019: -54.2%FY 2020: -29.3%FY 2021: -54.1%FY 2022: -36.2%FY 2023: -81.7%FY 2024: -100.8%FY 2025: -45.8%
FY 2016 5y median -54.1% FY 2025

Growth (YoY)

Revenue 29.7%
FY 2016: -52.5%FY 2017: 33.5%FY 2018: -2.4%FY 2019: 0.2%FY 2020: 81.3%FY 2021: 455.6%FY 2022: 356.1%FY 2023: -13.2%FY 2024: 27.8%FY 2025: 29.7%
FY 2016 FY 2025
Operating Income 18.8%
FY 2016: -67.9%FY 2017: -58.4%FY 2018: -40.0%FY 2019: -45.9%FY 2020: -17.6%FY 2021: -29.4%FY 2022: -7.6%FY 2023: -34.0%FY 2024: 19.1%FY 2025: 18.8%
FY 2016 FY 2025
EPS (diluted) 49.0%
FY 2016: -59.0%FY 2017: -47.2%FY 2018: -30.4%FY 2019: -39.1%FY 2020: -10.9%FY 2021: -23.5%FY 2022: -10.3%FY 2023: -16.4%FY 2024: 18.9%FY 2025: 49.0%
FY 2016 FY 2025
Free Cash Flow 18.6%
FY 2016: -61.6%FY 2017: -59.6%FY 2018: -35.8%FY 2019: -63.3%FY 2020: 14.1%FY 2021: -66.4%FY 2022: -4.7%FY 2023: -49.4%FY 2024: 10.7%FY 2025: 18.6%
FY 2016 FY 2025

Financial Health

Current Ratio 1.9×
FY 2016: 10.0×FY 2017: 14.3×FY 2018: 12.0×FY 2019: 6.5×FY 2020: 12.2×FY 2021: 5.5×FY 2022: 6.1×FY 2023: 2.7×FY 2024: 2.3×FY 2025: 1.9×
FY 2016 5y median 2.7× FY 2025
Quick Ratio 1.9×
FY 2016: 10.0×FY 2017: 14.3×FY 2018: 12.0×FY 2019: 6.5×FY 2020: 12.2×FY 2021: 5.5×FY 2022: 6.1×FY 2023: 2.7×FY 2024: 2.3×FY 2025: 1.9×
FY 2016 5y median 2.7× FY 2025
Debt / Equity -10.5×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 1.3×FY 2023: -5.2×FY 2024: -1.8×FY 2025: -10.5×
FY 2016 5y median -1.8× FY 2025
Net Debt / EBITDA -0.6×
FY 2016: 2.0×FY 2017: 3.4×FY 2018: 1.8×FY 2019: 0.5×FY 2020: 2.7×FY 2021: 1.1×FY 2022: 1.3×FY 2023: -0.2×FY 2024: -1.0×FY 2025: -0.6×
FY 2016 5y median -0.2× FY 2025
Interest Coverage -4.4×
FY 2016: -1079×FY 2017: -253×FY 2018: -349×FY 2019: -772×FY 2020: -1645×FY 2021: -788×FY 2022: -13.5×FY 2023: -7.5×FY 2024: -3.4×FY 2025: -4.4×
FY 2016 5y median -7.5× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31